目前，肺移植的发展仍然落后于心、肝和肾的移植，这是因为肺对缺血再灌注损伤非常敏感，加上供肺来源困难，限制了肺移植的发展。因此，改善移植肺的缺血再灌注损伤，保护肺功能，将促进肺移植的发展。目前的研究已证明，人参皂式对心脏和脑的缺血再灌注损伤有明显保护作用。 At present, the development of lung transplantation still lags behind the transplantation of heart, liver and kidney. This is because the lung is very sensitive to ischemia-reperfusion injury, and the source of lung supply is difficult, which limits the development of lung transplantation. Therefore, improving the ischemia-reperfusion injury of transplanted lungs and protecting lung function will promote the development of lung transplantation. Current research has demonstrated that ginsenosides have significant protective effects on heart and brain ischemia-reperfusion injury.